Blastic plasmacytoid dendritic cell neoplasm: challenges and future prospects

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare CD4+ CD56+ myeloid malignancy that is challenging to diagnose and treat. BPDCN typically presents with nonspecific cutaneous lesions with or without extra-cutaneous manifestations before progressing to leukemia. Currently, there is no st...

Descripción completa

Detalles Bibliográficos
Autores principales: Trottier, Amy M, Cerquozzi, Sonia, Owen, Carolyn J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467341/
https://www.ncbi.nlm.nih.gov/pubmed/31360087
http://dx.doi.org/10.2147/BLCTT.S132060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467341/
https://www.ncbi.nlm.nih.gov/pubmed/31360087
http://dx.doi.org/10.2147/BLCTT.S132060

Ejemplares similares